Over-modulated plan undermines prognosis of small cell lung cancer patients treated under free-breathing: analysis based on a multicenter, open-label, phase 3 trial
Radiation Medicine and Protection · 2026-06 · 7 (3) · 137-142
DOI: 10.1016/j.radmp.2026.04.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Radiation Medicine and Protection, 2026-06. Verfasst von Junqian Yang und 14 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Peking University, Beijing Natural Science Foundation, National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Peking University
- Beijing Natural Science Foundation
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Yang, J., Yu, J., Guan, Y., Li, Z., Wang, J., Yao, X., Zhang, W., Hou, J., Wang, Z., Lu, Q., Chen, L., Yu, S., Jiang, Y., Shi, A., & Zhang, Y. (2026). Over-modulated plan undermines prognosis of small cell lung cancer patients treated under free-breathing: analysis based on a multicenter, open-label, phase 3 trial. Radiation Medicine and Protection, 7(3), 137-142. https://doi.org/10.1016/j.radmp.2026.04.007
Vancouver
Yang J, Yu J, Guan Y, Li Z, Wang J, Yao X, et al. Over-modulated plan undermines prognosis of small cell lung cancer patients treated under free-breathing: analysis based on a multicenter, open-label, phase 3 trial. Radiation Medicine and Protection. 2026;7(3):137-142. doi:10.1016/j.radmp.2026.04.007
BibTeX
@article{Yang2026,
author = {Yang, Junqian and Yu, Jiayi and Guan, Ying and Li, Zhengxian and Wang, Jiazhou and Yao, Xinghong and Zhang, Wei and Hou, Jixiang and Wang, Zhenli and Lu, Qijian and Chen, Lekang and Yu, Shutong and Jiang, Yin and Shi, Anhui and Zhang, Yibao},
title = {Over-modulated plan undermines prognosis of small cell lung cancer patients treated under free-breathing: analysis based on a multicenter, open-label, phase 3 trial},
journal = {Radiation Medicine and Protection},
year = {2026},
volume = {7},
number = {3},
pages = {137--142},
doi = {10.1016/j.radmp.2026.04.007}
}
EUVIMED